Study examines magnitude of drug shortages

11/14/2011 | Family Practice News

An IMS Institute analysis shows that more than 80% of 168 drug shortages involve generic products, and more than 80% affect injectable treatments. Two-thirds treat cancer, infection, heart illness, diseases of the central nervous system and pain. The report includes data on the supply chain and calls for early shortage notification.

View Full Article in:

Family Practice News